Literature DB >> 9363098

Pulmonary involvement in systemic lupus erythematosus.

N Fishback1, M N Koss.   

Abstract

Pulmonary disorders in systemic lupus erythematosus involve a variety of clinical presentations and pathologic patterns, which can be difficult to diagnose due to systemic dysfunction, infection, or complications of therapy. The causes of dyspnea in systemic lupus erythematosus are multifactorial, and the clinical manifestations of lung disease widely vary. Biopsy is frequently relied on to evaluate and diagnose pulmonary disease in systemic lupus erythematosus. The patient who has systemic lupus erythematosus-associated lung disease is effectively treated with various immunosuppressive drugs, in conjunction with careful evaluation of the patient's systemic involvement, drug-induced complications, and the ever-present threat of infection.

Entities:  

Mesh:

Year:  1995        PMID: 9363098

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  4 in total

Review 1.  Pleuropulmonary manifestations of systemic lupus erythematosus.

Authors:  M P Keane; J P Lynch
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

Review 2.  Clinical mimics: an emergency medicine focused review of pneumonia mimics.

Authors:  Drew Alan Long; Brit Long; Alex Koyfman
Journal:  Intern Emerg Med       Date:  2018-03-26       Impact factor: 3.397

3.  Shrinking lung syndrome in systemic lupus erythematosus-scleroderma overlap.

Authors:  Vivek S Guleria; Pradeep K Singh; Puneet Saxena; Shankar Subramanian
Journal:  Lung India       Date:  2014-10

4.  Age-adjusted Charlson comorbidity score is associated with the risk of empyema in patients with COPD.

Authors:  Chung-Han Ho; Yi-Chen Chen; Chin-Chen Chu; Jhi-Joung Wang; Kuang-Ming Liao
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.